Keywords: Ipsen, Braintree Labs, Eziclen, Izinova, EU approval, Bowel cleansing

Launch of Ipsen/Braintree's Eziclen/Izinova in Europe expected by end 2013

Article | 07 February 2013

French drugmaker Ipsen (Euronext: IPN) and US partner Braintree Laboratories yesterday announced today that Eziclen/Izinova (BLI-800) has successfully completed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Ipsen

Braintree Laboratories

Go to company listing

Related Drugs

Izinova

Eziclen

Go to drug listing